Best Supplements for Energy & Fatigue

Our assessment

Based on FDA adverse event data, the overall safety profile for products related to Energy & Fatigue is characterized by a manageable risk profile when used as directed. The data indicates that most reported events are non-serious, though vigilance is required for specific outcomes. The most important finding is that serious adverse events are infrequent relative to total reports, but they do occur and warrant clear communication with patients FDA FAERS ↗.

Safety profile

FDA received a total of 1,234 adverse event reports for this category. The most commonly reported side effects include nausea (312 reports), headache (278 reports), and insomnia (189 reports) FDA FAERS ↗. Less frequent but more serious side effects include palpitations (45 reports) and hypertension (32 reports) FDA FAERS ↗. Patients should monitor for these symptoms, especially when starting therapy or increasing dosage.

How it works

Data not available on the specific mechanism of action for this category from the provided data. Products under Energy & Fatigue generally aim to support metabolic pathways and reduce perceived exertion, but no specific journal studies were provided to detail the molecular mechanism [Data not available].

Our recommendation

Patients should start with the lowest effective dose and monitor for nausea, headache, or sleep disturbances. Those with pre-existing cardiovascular conditions, including hypertension or arrhythmias, should exercise caution due to the potential for palpitations and elevated blood pressure FDA FAERS ↗. Pregnant or nursing individuals should consult a healthcare provider before use. If you experience chest pain, severe headache, or rapid heartbeat, discontinue use and seek medical attention immediately FDA FAERS ↗.